Abstract: In most countries with high HIV prevalence, the demand for treatment with antiretroviral therapy (ART) has rapidly outstripped the capacity of traditional tertiary health-care facilities (hospitals) to provide that treatment. If national and international targets for treatment access are to be met, ART will therefore need to be delivered in a wide range of settings and at multiple levels of the health-care system, from large referral hospitals in capital cities to primary
